Lymphoma
Alterative Donor HSCT
Minimal Change Disease
The Christie NHS Foundation Trust Palliative Care: Are we doing enough? Louise Burgess and Josie Daines – Wright June 2012.
Clique para editar o título mestre. Secondary Cytoreduction In Recurrent Ovarian Cancer Robert L. Coleman, M.D. Professor & Vice Chair, Clinical Research.
The Bruton’s Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) Promotes High Response Rate, Durable Remissions, and is Tolerable in Treatment- Naïve.
K30 Case Presentation David Andorsky August 26, 2008.
K30 Case Presentation
Novel treatment options for Waldenstrom Macroglobulinemia
Radiotherapy in Pediatric Hodgkin Lymphoma
